Educational Resources


Understanding a Biological Basis for Infection-Triggered Autoimmune Neuropsychiatric Disorders & Targets in the Panel & Clinical Case Studies on Diagnosis and Treatment

Play Video

Webinar Info

  • Presenters:
    Craig Shimasaki, PhD, MBA – President & CEO, Moleculera Labs
    Eboni Cornish, MD – Amen Clinics
  • Aired: November 4, 2022


Neurologic, psychiatric, and behavioral symptoms can result from a number of different etiologies. When the underlying root is an autoimmune encephalopathy or basal ganglia encephalitis, treatments that have shown effectiveness include anti-infectives, anti-inflammatory and immune modulatory modalities.

This webinar will explain the clinical significance of autoimmune antibodies directed against brain and neuronal targets, and the types of symptoms that have been associated with them. We will review some of the most common presenting symptoms associated with positive Panel, and share published clinical data on patients’ before and after effective treatment.

Dr. Craig Shimasaki will review the clinical significance of autoimmune antibodies against brain and neuronal targets, and the types of symptoms that have been associated with them, along with some of the most common presenting symptoms associated with positive Panel results.

Dr. Eboni Cornish will present and discuss clinical cases, including the therapeutic interventions used for patients with infection-triggered autoimmune encephalopathies.


Craig Shimasaki, PhD, MBA
President & CEO Moleculera Labs, Inc.

Dr. Shimasaki received his BS in Biochemistry from the University of California at Davis, his PhD in Molecular Biology and Biotechnology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He is an Adjunct Professor at the University of Oklahoma and is the cofounder and CEO of Moleculera Labs, a neuroimmunology precision medicine company focused on identifying the underlying roots of neurologic, psychiatric, and behavioral disorders triggered by an autoimmune response. He has spent over 35 years working in the fields of molecular biology, viral pathogenesis, and infection-triggered autoimmune neuropsychiatric disorders.

Dr. Shimasaki started his career at Genentech and has worked across all stages of research, development, clinical trials, and regulatory approval of technology innovation from bench-to-bedside. His research work includes epitope mapping of HIV proteins, genetic-based predictors of breast cancer risk, influenza and RSV diagnostics and therapeutics, and the pathogenesis of infection-triggered neuropsychiatric disorders. He has co-founded multiple companies and led multiple products through the FDA approval process and is a co-inventor on multiple patents. Internationally, he teaches and mentors scientists, physicians and biotech leaders on how to translate their research into acutely needed medical interventions. His passion is to translate scientific discoveries into acutely needed products so that more patients can live longer, healthier lives.

Eboni Cornish, MD
Amen Clinics

Dr. Eboni Cornish graduated from Brown University undergraduate with honors and Brown University Medical School. She completed her family medicine residency at Georgetown University. In 2003, as a Howard Hughes Medical Fellow, Dr. Cornish conducted translational research at the National Human Genome Research Institute of NIH. She was an apprentice in the laboratory of Francis Collins, M.D Ph.D., the current Director of NIH and leader of the Human Genome Project. Under his leadership, she analyzed genetic associations of chronic illnesses.

At Amen Clinics, Dr. Cornish specializes in the treatment of Lyme Disease, environmental toxicity, methylation disorders, and Morgellons Disease among other chronic conditions. Dr. Cornish’s approach to the treatment of chronic disease is to find the root cause of a person’s health problems by performing a comprehensive evaluation of the body’s various biological systems and takes an approach based on integrative strategies of healing.

She currently serves as a board member of the International Lyme and Associated Diseases Society Educational Foundation. She is a member of the American College for Advancement in Medicine (ACAM) and the Institute of Functional Medicine (IFM). She was nominated and awarded Northern Virginia Top Doctor for family practice in 2021. She has combined her passion for integrative/functional medicine, interest in chronic illness and extensive genetic research experience at NIH to manage the challenges facing many patients of Amen Clinics.

This webinar is intended only for Medical Professionals.

The webinar content has been made available for informational purposes only. The information provided is not intended to be medical or healthcare advice for any individual medical problem, nor a substitute for medical or professional advice and services from a qualified healthcare provider.

By attending or viewing the webinar, you acknowledge and agree that we have not represented that any content provided in this webinar has the ability to diagnose a medical condition, prescribe treatment, or perform any other tasks that constitute the practice of medicine.

Moleculera hereby disclaims any and all liability to any party for any direct, indirect, implied, punitive, special, incidental, or other consequential damages arising directly or indirectly from any use of the webinar content, which is provided as is, and without warranties.

All rights reserved. No part of this presentation may be reproduced, distributed, or transmitted in any form or by any means, including recording, photocopying, or other electronic or other methods without the prior written consent of the publisher.